ADAPT SMART is an enabling platform for the coordination of Medicines Adaptive Pathways to Patients (MAPPs) activities. MAPPs seeks to foster access to beneficial treatments for the right patient groups at the earliest appropriate time in the product life-span in a sustainable fashion.
ADAPT SMART will support IMI2 projects investigating MAPPs tools and methodologies, and engage in a dialogue with all relevant stakeholders to prove and develop workable MAPPs concepts.
The ADAPT SMART consortium aims to facilitate and accelerate the availability of MAPPs to all healthcare stakeholders. It will:
- Distribute findings, key discoveries and case studies from ongoing or completed MAPPs pilot projects, creating a MAPPs repository of knowledge and opportunities
- Identify the scientific challenges and opportunities related to the implementation of MAPPs and foster the aligned understanding of consortium members and their constituents
- Support new IMI2 research and innovation actions by facilitating the inclusion of MAPPs enablers, tools and methodologies to address its challenges and opportunities
- Conduct horizon scanning and research on key topics to produce actionable advice and recommendations for IMI and other stakeholders to further the broad implementation and adoption of MAPPs
The ADAPT SMART glossary provides working definitions for common terms relevant for the consortium and includes references. The glossary is based on the input from members of the ADAPT SMART consortium representing different stakeholder groups. The definitions are based on relevant legislation or literature sources and written in the context of the […]
There is much debate about the need to allow patients with serious diseases early access to promising new therapies. Some concerned stakeholders argue for “the right to try any treatment option for every patient in need” while others oppose this position, saying “only thoroughly studied treatments should be allowed on […]
Amsterdam, The Netherlands
On the 29th of February, ADAPT SMART will be hosting an invitation-only multi-stakeholder workshop around selection criteria for MAPPs in Amsterdam, The Netherlands. MAPPs seek to foster access to beneficial treatments for the right patient groups at the earliest appropriate time in the product life span in a sustainable and affordable fashion.
European Medicines Agency, London, UK
On the 4th of September, the Consortium participants of the ADAPT SMART project met at the EMA in London. This meeting officially launched the ADAPT SMART collaboration. The ADAPT SMART consortium aims to facilitate and accelerate the availability of MAPPs to all healthcare stakeholders. A full event report with details of the 4th September event is available on the ADAPT SMART website.